Price $11.14 |
Market Cap
307.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
21.2
|
P/B
5.55
|
P/S
1.75
|
Dividend %
-
|
|
P/CF
18.2
|
P/FCF
21.5
|
Op. Cash Flow
16.3K
|
FCF
0.4
|
|
Op. Margin
10.00%
|
Net Margin
8.60%
|
ROE
25.40%
|
ROI
23.00%
|
|
ROA
12.00%
|
EPS Growth
-9.20%
|
Current Ratio
3.3
|
Debt/Equity
8.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Vericel Corp (VCEL) | $45.38 | - | - | 1.69B | Strong Buy |
| Myomo Inc (MYO) | $3.44 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.10 | - | - | 8.6M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $2.27 | - | - | 12.8M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.13 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
